You are here

lenzilumab

FDA slams the door in Humanigen’s face, rejects emergency use green light, wants more data

Fierce Biotech

Thu, 09/9/21 - 10:50 am

Emergency Use Authorization

Humanigen says its antibody reduced need for ventilation in COVID-19 patients by 54%

Beckers Hospital Review

Wed, 03/31/21 - 10:34 am

Humanigen announces first patient dosed in phase 3 clinical study of lenzilumab in Covid-19

Pharmaceutical Business Review

Mon, 11/2/20 - 10:22 am

clinical trials

A drug from Shkreli's former company Humanigen shows early promise in COVID-19

Fierce Biotech

Wed, 06/17/20 - 10:37 am